New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 6, 2014
08:02 EDTMASIMasimo says CFD study shows SET Pulse Oximetry as effective tool
Masimo announced that the largest-ever study of newborn screening for congenital heart disease, or CHD, was published online by The Lancet. The study of 122,738 newborns -- more than twice as large as any previous study of this type -- was conducted using Masimo SET Measure-through Motion and Low Perfusion Pulse Oximetry and showed that Masimo SET pulse oximetry screening significantly increased the rate of CHD detection and is "feasible and reliable" for detecting major congenital heart disease. Congenital heart defects are a leading cause of infant death in high-income countries, and affect eight of 1,000 livebirths. Critical congenital heart disease, or CCHD, defined as causing death or requiring invasive intervention in the neonatal period, occurs in one to two newborns per 1,000 livebirths. Without CCHD detection and intervention, serious injury or death is common.
News For MASI From The Last 14 Days
Check below for free stories on MASI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 15, 2014
07:59 EDTMASIMasimo receives warning letter from FDA regarding compliance at Irvine facility
Subscribe for More Information
August 8, 2014
10:00 EDTMASIOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
05:33 EDTMASIMasimo downgraded to Neutral from Overweight at Piper Jaffray
Subscribe for More Information
August 7, 2014
16:20 EDTMASIMasimo sees FY14 EPS $1.24-$1.30, consensus $1.28
Subscribe for More Information
16:19 EDTMASIMasimo reports Q2 EPS 24c, consensus 29c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use